Evidence map›Paper›PMID 38952126›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Immobilized NRG1 Accelerates Neural Crest like Cell Differentiation Toward Functional Schwann Cells Through Sustained Erk1/2 Activation and YAP/TAZ Nuclear Translocation.

Georgios Tseropoulos, Pihu Mehrotra, Ashis Kumer Podder, Emma Wilson, Yali Zhang, Jianmin Wang, Alison Koontz, Nan Papili Gao, Rudiyanto Gunawan, Song Liu and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Georgios TseropoulosDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Pihu MehrotraDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Ashis Kumer PodderDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Emma WilsonHunter James Kelly Research Institute, Jacobs School of Medicine and Biomedical Sciences State, University of New York at Buffalo, Buffalo, NY, 14203, USA.
Yali ZhangDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14203, USA.
Jianmin WangDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14203, USA.
Alison KoontzDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91126, USA.
Nan Papili GaoDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Rudiyanto GunawanDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.
Song LiuDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14203, USA.
Laura M FeltriHunter James Kelly Research Institute, Jacobs School of Medicine and Biomedical Sciences State, University of New York at Buffalo, Buffalo, NY, 14203, USA.
Marianne E BronnerDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91126, USA.
Stelios T AndreadisDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY, 14260, USA.ORCID 0000-0001-9885-0457

Funding

Direct reprogramming of epidermal cells to neural crest derivatives for cell therapiesR01EB023114 · NIBIB · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ANDREADIS, STELIOS THEOHARIS · 2016 to 2019
$1.7M
New York State Stem Cell Science Contract #C30290GGNIBIB NIH HHS R01 EB023114NIH HHS R01 EB023114
6 · The paper itself

Abstract

Neural Crest cells (NC) are a multipotent cell population that give rise to a multitude of cell types including Schwann cells (SC) in the peripheral nervous system (PNS). Immature SC interact with neuronal axons via the neuregulin 1 (NRG1) ligand present on the neuronal surface and ultimately form the myelin sheath. Multiple attempts to derive functional SC from pluripotent stem cells have met challenges with respect to expression of mature markers and axonal sorting. Here, they hypothesized that sustained signaling from immobilized NRG1 (iNRG1) might enhance the differentiation of NC derived from glabrous neonatal epidermis towards a SC phenotype. Using this strategy, NC derived SC expressed mature markers to similar levels as compared to explanted rat sciatic SC. Signaling studies revealed that sustained NRG1 signaling led to yes-associated protein 1 (YAP) activation and nuclear translocation. Furthermore, NC derived SC on iNRG1 exhibited mature SC function as they aligned with rat dorsal root ganglia (DRG) neurons in an in vitro coculture model; and most notably, aligned on neuronal axons upon implantation in a chick embryo model in vivo. Taken together their work demonstrated the importance of signaling dynamics in SC differentiation, aiming towards development of drug testing platforms for de-myelinating disorders.

Indexed as

Cell DifferentiationNeural CrestNeuregulin-1Schwann CellsAnimalsCells, CulturedMAP Kinase Signaling SystemRatsRats, Sprague-DawleyYAP-Signaling ProteinsNeuregulin-1YAP-Signaling Proteinschick embryodemyelinating diseasesneural crest stem cellsneuregulinschwann cells

Identifiers

PMID38952126
PMCPMC11633358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.